Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial.

Michalowsky, Bernhard; Xie, Feng; Kilimann, Ingo; Eichler, Tilly; Thyrian, Jochen René; Zwingmann, Ina; Rädke, Anika; Hoffmann, Wolfgang; Hertel, Johannes; Wucherer, Diana; Teipel, Stefan

doi:10.1016/j.jalz.2019.05.008

Journal Article

DZNE-2020-07843

Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial.

Michalowsky, B. (First author)DZNE* ; Xie, F. ; Eichler, T.DZNE* ; Hertel, J.DZNE* ; Rädke, A.DZNE* ; Kilimann, I.DZNE* ; Teipel, S.DZNE* ; Wucherer, D.DZNE* ; Zwingmann, I.DZNE* ; Thyrian, J. R.DZNE* ; Hoffmann, W.DZNE*

2019
Elsevier Amsterdam [u.a.]

Alzheimer's and dementia 15(10), 1296-1308 (2019) [10.1016/j.jalz.2019.05.008]

This record in other databases:

Please use a persistent id in citations: doi:10.1016/j.jalz.2019.05.008

Abstract: The purpose of this study was to determine the cost-effectiveness of collaborative dementia care management (DCM).The cost-effectiveness analysis was based on the data of 444 patients of a cluster-randomized, controlled trial, conceptualized to evaluate a collaborative DCM that aimed to optimize treatment and care in dementia. Health-care resource use, costs, quality-adjusted life years (QALYs), and incremental cost per QALY gained were measured over a 24-month time horizon.DCM increased QALYs (+0.05) and decreased costs (-569€) due to a lower hospitalization and a delayed institutionalization (7 months) compared with usual care. The probability of DCM being cost-effective was 88% at willingness-to-pay thresholds of 40,000€ per QALY gained and higher in patients living alone compared to those not living alone (96% vs. 26%).DCM is likely to be a cost-effective strategy in treating dementia and thus beneficial for public health-care payers and patients, especially for those living alone.

Keyword(s): Aged (MeSH) ; Cooperative Behavior (MeSH) ; Cost-Benefit Analysis: statistics & numerical data (MeSH) ; Dementia: therapy (MeSH) ; Disease Management (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Patient Acceptance of Health Care: statistics & numerical data (MeSH) ; Quality-Adjusted Life Years (MeSH) ; Surveys and Questionnaires (MeSH)